JP Morgan Chase
INAB icon

JP Morgan Chase’s IN8bio INAB Stock Holding History

JP Morgan Chase’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$17 – 7363
2025
Q1 		$17 Sell
3
-1
-25% -$8 ﹤0.01% 7146
2024
Q4 		$29 Buy
4
+1
+33% +$9 ﹤0.01% 7221
2024
Q3 		$23 Hold
3
– – ﹤0.01% 7241
2024
Q2 		$66 Buy
3
+1
+50% +$32 ﹤0.01% 6970
2024
Q1 		$81 Buy
2
+1
+100% +$38 ﹤0.01% 6947
2023
Q4 		$47 Hold
1
– – ﹤0.01% 7216
2023
Q3 		$19 Buy
+1
New +$38 ﹤0.01% 7176

Other funds holding INAB

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's INAB Position: Q2 2025 in Review

JP Morgan Chase sold out of IN8bio (INAB) in Q2 2025, closing a stake of 3 shares — an estimated $17 sold.

JP Morgan Chase first reported a position in INAB in Q3 2023 and held it in 7 quarters. The position peaked at $81 in Q1 2024. 12 funds tracked by Wall St. Rank hold INAB as of Q2 2025.

  • JP Morgan Chase reported no remaining IN8bio position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 3 IN8bio shares in Q2 2025, an estimated $17.
  • JP Morgan Chase first reported a position in IN8bio in Q3 2023 and held it in 7 quarters.
  • JP Morgan Chase's IN8bio position peaked at $81 in Q1 2024.
  • 12 funds tracked by Wall St. Rank held IN8bio as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.